MRI Interventions Inc (MRIC):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MRI Interventions Inc (MRIC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7869
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MRI Interventions Inc (MRI Interventions) is a medical equipment company that develops and commercializes platforms for performing invasive surgical procedures. The company’s products include systems used for performing invasive surgeries on brain and heart. Its products are used for treating neurological and cardiac diseases. MRI Interventions’ product provides real time MRI assistance for certain invasive procedures in the brain. The company has partnership with various medical device companies and academic institutions for the development and commercialization of its product platforms and core technologies. It serves physicians and hospitals. MRI Interventions is headquartered in Irvine, California, the US.

MRI Interventions Inc (MRIC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MRI Interventions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MRI Interventions Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MRI Interventions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MRI Interventions Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
MRI Interventions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
MRI Interventions Inc, Medical Equipment, Deal Details 11
Partnerships 11
MRI Interventions Enters into Licensing Agreement with Clinical Laserthermia Systems 11
MRI Interventions Enters into Co-development Agreement with Monteris Medical 12
MRI Interventions Enters into Licensing Agreement with Acoustic Medsystems 13
Clinical Laserthermia Systems Enters into Distribution Agreement with MRI Interventions 14
MRI Interventions Enters into Strategic Agreement with Voyager Therapeutics 15
MRI Interventions Enters into Co-Development Agreement with Mayo Clinic 16
MRI Interventions Enters Into Co-Development Agreement With Siemens Medical Solutions 17
Equity Offering 19
MRI Interventions Files Registration Statement for Public Offering of Shares for up to USD52.1 Million 19
MRI Interventions Raises USD13.3 Million in Private Placement of Units 20
MRI Interventions to Raise USD4.3 Million in Private Placement of Units 21
MRI Interventions to Raise USD5.2 Million in Private Placement of Units and Warrants 22
MRI Interventions Raises USD10.2 Million in Private Placement of Units 23
MRI Interventions Completes Private Placement Of Common Stock For US$11 Million 24
MRI Interventions Completes Private Placement Of Units For US$6 Million 25
MRI Interventions Completes IPO 26
MRI Interventions Inc – Key Competitors 27
MRI Interventions Inc – Key Employees 28
MRI Interventions Inc – Locations And Subsidiaries 29
Head Office 29
Recent Developments 30
Financial Announcements 30
Aug 14, 2018: MRI Interventions reports second quarter results 30
May 15, 2018: MRI Interventions Announces First Quarter 2018 Results 32
Mar 15, 2018: MRI Interventions Reports 34% Year-Over-Year Increase in Functional Neurology Revenues, 50% increase in Capital Sales 34
Feb 06, 2018: MRI Interventions Announces Record 629 ClearPoint Cases in 2017 37
Nov 06, 2017: MRI Interventions Reports 26% Year-Over-Year Increase in Third Quarter Procedures 38
Aug 01, 2017: MRI Interventions Reports 79% Revenue Increase and Record Treatments in Second Quarter 2017 41
Jul 11, 2017: MRI Interventions Announces Record Second Quarter ClearPoint System Procedures, And a 79% Year-Over-Year Revenue Increase 44
Apr 27, 2017: MRI Interventions Announces 2017 First Quarter Results 45
Apr 06, 2017: MRI Interventions Announces Record Quarterly Revenue, Record ClearPoint System Procedures in 2017 First Quarter 47
Feb 28, 2017: MRI Interventions Announces 2016 Fourth Quarter and Full Year Results 48
Jan 24, 2017: MRI Interventions Announces Year-End Update, Including 2016 Fourth Quarter and Full Year Revenues 51
Corporate Communications 52
Oct 09, 2017: MRI Interventions Announces Joseph Burnett As New President and CEO 52
May 11, 2017: Healthcare Veteran John Fletcher Joins MRI Interventions’ Board of Directors 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
MRI Interventions Inc, Medical Equipment, Key Facts, 2017 2
MRI Interventions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MRI Interventions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MRI Interventions Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
MRI Interventions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MRI Interventions Inc, Deals By Market, 2012 to YTD 2018 9
MRI Interventions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
MRI Interventions Enters into Licensing Agreement with Clinical Laserthermia Systems 11
MRI Interventions Enters into Co-development Agreement with Monteris Medical 12
MRI Interventions Enters into Licensing Agreement with Acoustic Medsystems 13
Clinical Laserthermia Systems Enters into Distribution Agreement with MRI Interventions 14
MRI Interventions Enters into Strategic Agreement with Voyager Therapeutics 15
MRI Interventions Enters into Co-Development Agreement with Mayo Clinic 16
MRI Interventions Enters Into Co-Development Agreement With Siemens Medical Solutions 17
MRI Interventions Files Registration Statement for Public Offering of Shares for up to USD52.1 Million 19
MRI Interventions Raises USD13.3 Million in Private Placement of Units 20
MRI Interventions to Raise USD4.3 Million in Private Placement of Units 21
MRI Interventions to Raise USD5.2 Million in Private Placement of Units and Warrants 22
MRI Interventions Raises USD10.2 Million in Private Placement of Units 23
MRI Interventions Completes Private Placement Of Common Stock For US$11 Million 24
MRI Interventions Completes Private Placement Of Units For US$6 Million 25
MRI Interventions Completes IPO 26
MRI Interventions Inc, Key Competitors 27
MRI Interventions Inc, Key Employees 28

List of Figures
MRI Interventions Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MRI Interventions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MRI Interventions Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MRI Interventions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
MRI Interventions Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
MRI Interventions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
MRI Interventions Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[MRI Interventions Inc (MRIC):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • United Natural Foods Inc:企業の戦略・SWOT・財務情報
    United Natural Foods Inc - Strategy, SWOT and Corporate Finance Report Summary United Natural Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Checkpoint Systems, Inc.:企業の戦略・SWOT・財務分析
    Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Suncor Energy Inc (SU):企業の財務・戦略的SWOT分析
    Suncor Energy Inc (SU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Genomind Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genomind Inc (Genomind) is a personalized medicine company that provides genetic testing services. The company offers Genecept Assay, a pharmacogenetic test designed to help clinicians optimize treatment decisions for their patients with mental illness. Its test is used to guide treatment fo …
  • Bulgarian Energy Holding EAD:企業の戦略的SWOT分析
    Bulgarian Energy Holding EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • E.ON UK Plc:企業の発電所・SWOT分析2018
    E.ON UK Plc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • StarTek Inc (SRT):企業の財務・戦略的SWOT分析
    Summary StarTek Inc (StarTek) is a business process outsourcing company that offers contact center and customer engagement solutions. The company offers service solutions, technology solutions and customer experience suppor. Its service solution provides multi-channel customer interactions across vo …
  • Deoleo, S.A.:企業の戦略・SWOT・財務情報
    Deoleo, S.A. - Strategy, SWOT and Corporate Finance Report Summary Deoleo, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sui Northern Gas Pipelines Ltd (SNGP):企業の財務・戦略的SWOT分析
    Sui Northern Gas Pipelines Ltd (SNGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Virgin Australia Holdings Limited:企業のM&A・事業提携・投資動向
    Virgin Australia Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Virgin Australia Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Dean Foods Co:企業のM&A・事業提携・投資動向
    Dean Foods Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dean Foods Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • UCB SA (UCB)-製薬・医療分野:企業M&A・提携分析
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • Avingtrans Plc (AVG):企業の財務・戦略的SWOT分析
    Avingtrans Plc (AVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sharjah Electricity & Water Authority:企業の戦略的SWOT分析
    Sharjah Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • NuStar GP Holdings LLC (NSH):企業の財務・戦略的SWOT分析
    Summary NuStar GP Holdings LLC (NuStar) is an oil and gas company that offers transportation and logistics services to petroleum products and anhydrous ammonia. The company offers services such as terminalling and storage of petroleum products, petroleum refining and marketing, and transportation of …
  • Natco Pharma Ltd (NATCOPHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Natco Pharma Ltd (Natco Pharma) focuses on the research, development, manufacture and commercialization of pharmaceutical substances and finished dosage forms. The company offers finished dosage forms in capsule, injection and tablet. Its products are indicated to treat multiple sclerosis, i …
  • Channel Four Telivision Corp:企業の戦略的SWOT分析
    Channel Four Telivision Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • PLx Pharma Inc (PLXP):製薬・医療:M&Aディール及び事業提携情報
    Summary PLx Pharma Inc (PLx Pharma) is a pharmaceutical company that develops patent-protected delivery systems. The company offers products such as PLxGuard delivery system, PLxGuard pipeline products, and PL1100 and PL1200 ibuprofen products. Its PLxGuard delivery system are used in enhancement of …
  • Fortis Inc.:企業の戦略・SWOT・財務情報
    Fortis Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortis Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kenzo Parfums NA, LLC:企業の戦略・SWOT・財務情報
    Kenzo Parfums NA, LLC - Strategy, SWOT and Corporate Finance Report Summary Kenzo Parfums NA, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆